Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Therapeutic potential of Relaxin-2 in Heart Failure with preserved Ejection Fraction (HFpEF).
Journal: bioRxiv : the preprint server for biology
Published: June 04, 2026
Therapeutic potential of Relaxin-2 in Heart Failure with preserved Ejection Fraction (HFpEF).
Journal: bioRxiv : the preprint server for biology
Published: June 04, 2026
Differential Responses of Salmonella enterica Typhimurium, S. enteritidis, and S. infantis to Chlorine Dioxide In Vitro: Impacts on Growth and Biofilm Development.
Journal: Microorganisms
Published: March 17, 2026
Relaxin suppresses atrial fibrillation, reverses fibrosis and reduces inflammation in aged hearts.
Journal: Biochemical pharmacology
Published: March 19, 2024
Periodic injections of Relaxin 2, its pharmacokinetics and remodeling of rat hearts.
Journal: Biochemical pharmacology
Published: December 14, 2023
Relaxin abrogates genomic remodeling of the aged heart.
Journal: Vitamins and hormones
Published: March 12, 2021
Relaxin Inhibits Ventricular Arrhythmia and Asystole in Rats With Pulmonary Arterial Hypertension.
Journal: Frontiers in cardiovascular medicine
Published: February 15, 2021
Relaxin reverses maladaptive remodeling of the aged heart through Wnt-signaling.
Journal: Scientific reports
Published: February 05, 2019
Cardioprotective actions of relaxin.
Journal: Molecular and cellular endocrinology
Published: October 24, 2018
Relaxin reverses inflammatory and immune signals in aged hearts.
Journal: PloS one
Published: August 14, 2017
Characterization of Endocytic Vesicles Using Magnetic Microbeads Coated with Signaling Ligands.
Journal: Traffic (Copenhagen, Denmark)
Published: June 29, 2016
Last Updated: 09/26/2026